FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Gerd Sutter

Research Profile

Living Beings

Chemicals & Drugs

Anatomy

Procedures

Co-author Network

Publications

TOP 3
Stefan Zimmerling; Theresa Resch; Gerd Sutter; Zoe Waibler; Astrid Schwantes
Interleukin-1β receptor expressed by modified vaccinia virus Ankara interferes with interleukin-1β activity produced in various virus-infected antigen-presenting cells.
Melanie Kremer; Michael H Lehmann; Robert Fux; Joost H C M Kreijtz; Asisa Volz; Gerd Sutter
Easy and efficient protocols for working with recombinant vaccinia virus MVA.
Melanie Kremer; Michael H Lehmann; Monir Majzoub; Yasemin Suezer; Theresa Frenz; Kay-Martin Hanschmann; Ulrich Kalinke; Asisa Volz; Gerd Sutter
Critical role of perforin-dependent CD8+ T cell immunity for rapid protective vaccination in a murine model for human smallpox.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Gerd Sutter (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Stefan Zimmerling; Theresa Resch; Gerd Sutter; Zoe Waibler; Astrid Schwantes
Interleukin-1β receptor expressed by modified vaccinia virus Ankara interferes with interleukin-1β activity produced in various virus-infected antigen-presenting cells.
Virology journal 2013;10():34.
2012: Melanie Kremer; Michael H Lehmann; Robert Fux; Joost H C M Kreijtz; Asisa Volz; Gerd Sutter
Easy and efficient protocols for working with recombinant vaccinia virus MVA.
Methods in molecular biology (Clifton, N.J.) 2012;890():59-92.
2012: Melanie Kremer; Michael H Lehmann; Monir Majzoub; Yasemin Suezer; Theresa Frenz; Kay-Martin Hanschmann; Ulrich Kalinke; Asisa Volz; Gerd Sutter
Critical role of perforin-dependent CD8+ T cell immunity for rapid protective vaccination in a murine model for human smallpox.
PLoS pathogens 2012;8(3):e1002557.
2011: Christin Flechsig; Hermann Einsele; Markus Kapp; Jürgen Löffler; Yasemin Suezer; Gerd Sutter; Sen Mui Tan; Goetz Ulrich Grigoleit
Uptake of antigens from modified vaccinia Ankara virus-infected leukocytes enhances the immunostimulatory capacity of dendritic cells.
Cytotherapy 2011;13(6):739-52.
2011: Pedro Eitz Ferrer; Georg Gasteiger; Ingo Drexler; Wolfgang Kastenmüller; Susanne Kirschnek; Holger Ludwig; Stefan A Paschen; Stephanie Potthoff; Gerd Sutter; Andreas Villunger; Georg Häcker
Induction of Noxa-mediated apoptosis by modified vaccinia virus Ankara depends on viral recognition by cytosolic helicases, leading to IRF-3/IFN-β-dependent induction of pro-apoptotic Noxa.
PLoS pathogens 2011;7(6):e1002083.
2011: Meike S Gratz; Yasemin Suezer; Melanie Kremer; Asisa Volz; Monir Majzoub; Kay-Martin Hanschmann; Ulrich Kalinke; Astrid Schwantes; Gerd Sutter
N1L is an ectromelia virus virulence factor and essential for in vivo spread upon respiratory infection.
Journal of virology 2011;85(7):3557-69.
2010: Joost H C M Kreijtz; Yasemin Süzer; Rogier Bodewes; Astrid Schwantes; Geert van Amerongen; R Joyce Verburgh; Gerrie de Mutsert; Judith van den Brand; Stella E van Trierum; Thijs Kuiken; Ron A M Fouchier; Albert D M E Osterhaus; Gerd Sutter; Guus F Rimmelzwaan
Evaluation of a modified vaccinia virus Ankara (MVA)-based candidate pandemic influenza A/H1N1 vaccine in the ferret model.
The Journal of general virology 2010;91(Pt 11):2745-52.
2010: Theresa Frenz; Zoe Waibler; Janin Hofmann; Matthias Hamdorf; Markus Lantermann; Boris Reizis; Michaël G Tovey; Peter Aichele; Gerd Sutter; Ulrich Kalinke
Concomitant type I IFN receptor-triggering of T cells and of DC is required to promote maximal modified vaccinia virus Ankara-induced T-cell expansion.
European journal of immunology 2010;40(10):2769-77.
2010: Joachim Zwilling; Katja Sliva; Astrid Schwantes; Barbara S Schnierle; Gerd Sutter
Functional F11L and K1L genes in modified vaccinia virus Ankara restore virus-induced cell motility but not growth in human and murine cells.
Virology 2010;404(2):231-9.
2010: Simone Backes; Karin Sperling; Joachim Zwilling; Georg Gasteiger; Holger Ludwig; Elisabeth Kremmer; Astrid Schwantes; Caroline Staib; Gerd Sutter
Viral host-range factor C7 or K1 is essential for modified vaccinia virus Ankara late gene expression in human and murine cells, irrespective of their capacity to inhibit protein kinase R-mediated phosphorylation of eukaryotic translation initiation factor 2alpha.
The Journal of general virology 2010;91(Pt 2):470-82.
2009: Nir Paran; Gerd Sutter
Smallpox vaccines: New formulations and revised strategies for vaccination.
Human vaccines 2009;5(12):824-31.
2009: Stephan Halle; Hélène C Dujardin; Nadja Bakocevic; Henrike Fleige; Heike Danzer; Stefanie Willenzon; Yasemin Suezer; Günter Hämmerling; Natalio Garbi; Gerd Sutter; Tim Worbs; Reinhold Förster
Induced bronchus-associated lymphoid tissue serves as a general priming site for T cells and is maintained by dendritic cells.
The Journal of experimental medicine 2009;206(12):2593-601.
2009: J H C M Kreijtz; Yasemin Suezer; Gerrie de Mutsert; Judith van den Brand; Geert van Amerongen; Barbara S Schnierle; Thijs Kuiken; Ron A M Fouchier; Johannes Löwer; A D M E Osterhaus; Gerd Sutter; Guus F Rimmelzwaan
Preclinical evaluation of a modified vaccinia virus Ankara (MVA)-based vaccine against influenza A/H5N1 viruses.
Vaccine 2009;27(45):6296-9.
2009: Karin Sperling; Astrid Schwantes; Caroline Staib; Barbara S Schnierle; Gerd Sutter
The orthopoxvirus 68-kilodalton ankyrin-like protein is essential for DNA replication and complete gene expression of modified vaccinia virus Ankara in nonpermissive human and murine cells.
Journal of virology 2009;83(12):6029-38.
2009: Guus F Rimmelzwaan; Gerd Sutter
Candidate influenza vaccines based on recombinant modified vaccinia virus Ankara.
Expert review of vaccines 2009;8(4):447-54.
2009: Michael H Lehmann; Wolfgang Kastenmuller; Judith D Kandemir; Florian Brandt; Yasemin Suezer; Gerd Sutter
Modified vaccinia virus ankara triggers chemotaxis of monocytes and early respiratory immigration of leukocytes by induction of CCL2 expression.
Journal of virology 2009;83(6):2540-52.
2009: Zoe Waibler; Martina Anzaghe; Theresa Frenz; Astrid Schwantes; Christopher Pöhlmann; Holger Ludwig; Marcos Palomo-Otero; Antonio Alcamí; Gerd Sutter; Ulrich Kalinke
Vaccinia virus-mediated inhibition of type I interferon responses is a multifactorial process involving the soluble type I interferon receptor B18 and intracellular components.
Journal of virology 2009;83(4):1563-71.
2009: J H C M Kreijtz; Yasemin Suezer; G de Mutsert; Judith van den Brand; G van Amerongen; Barbara S Schnierle; Thijs Kuiken; Ron A M Fouchier; Johannes Löwer; A D M E Osterhaus; Gerd Sutter; Guus F Rimmelzwaan
Recombinant modified vaccinia virus Ankara expressing the hemagglutinin gene confers protection against homologous and heterologous H5N1 influenza virus infections in macaques.
The Journal of infectious diseases 2009;199(3):405-13.
2009: Joost H C M Kreijtz; Yasemin Suezer; Gerrie de Mutsert; Geert van Amerongen; Astrid Schwantes; Judith van den Brand; Ron A M Fouchier; Johannes Löwer; Albert D M E Osterhaus; Gerd Sutter; Guus F Rimmelzwaan
MVA-based H5N1 vaccine affords cross-clade protection in mice against influenza A/H5N1 viruses at low doses and after single immunization.
PloS one 2009;4(11):e7790.
2009: Nir Paran; Yasemin Suezer; Shlomo Lustig; Tomer Israely; Astrid Schwantes; Sharon Melamed; Lior Katz; Thomas Preuss; Kay-Martin Hanschmann; Ulrich Kalinke; Noam Erez; Reuven Levin; Baruch Velan; Johannes Löwer; Avigdor Shafferman; Gerd Sutter
Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpox.
The Journal of infectious diseases 2009;199(1):39-48.
2008: Willem Huisman; Eefje J A Schrauwen; Edwin Tijhaar; Yasemin Süzer; Suzan D Pas; Geert van Amerongen; Gerd Sutter; Guus F Rimmelzwaan; Albert D M E Osterhaus
Evaluation of vaccination strategies against infection with feline immunodeficiency virus (FIV) based on recombinant viral vectors expressing FIV Rev and OrfA.
Veterinary immunology and immunopathology 2008;126(3-4):332-8.
2008: Melanie Albrecht; Yasemin Suezer; Caroline Staib; Gerd Sutter; Stefan Vieths; Gerald Reese
Vaccination with a Modified Vaccinia Virus Ankara-based vaccine protects mice from allergic sensitization.
The journal of gene medicine 2008;10(12):1324-33.
2008: Susanne El-Gogo; Britta Flach; Caroline Staib; Gerd Sutter; Heiko Adler
In vivo attenuation of recombinant murine gammaherpesvirus 68 (MHV-68) is due to the expression and immunogenicity but not to the insertion of foreign sequences.
Virology 2008;380(2):322-7.
2008: Karin Sperling; Astrid Schwantes; Barbara S Schnierle; Gerd Sutter
The highly conserved orthopoxvirus 68k ankyrin-like protein is part of a cellular SCF ubiquitin ligase complex.
Virology 2008;374(2):234-9.
2008: Jutta Veits; Angela Römer-Oberdörfer; Dorothee Helferich; Markus Durban; Yasemin Suezer; Gerd Sutter; Thomas C Mettenleiter
Protective efficacy of several vaccines against highly pathogenic H5N1 avian influenza virus under experimental conditions.
Vaccine 2008;26(13):1688-96.
2008: Susanne El-Gogo; Caroline Staib; Juan José Lasarte; Gerd Sutter; Heiko Adler
Protective vaccination with hepatitis C virus NS3 but not core antigen in a novel mouse challenge model.
The journal of gene medicine 2008;10(2):177-86.
2007: Zoe Waibler; Martina Anzaghe; Holger Ludwig; Shizuo Akira; Siegfried Weiss; Gerd Sutter; Ulrich Kalinke
Modified vaccinia virus Ankara induces Toll-like receptor-independent type I interferon responses.
Journal of virology 2007;81(22):12102-10.
2007: Georg Gasteiger; Wolfgang Kastenmuller; Ronny Ljapoci; Gerd Sutter; Ingo Drexler
Cross-priming of cytotoxic T cells dictates antigen requisites for modified vaccinia virus Ankara vector vaccines.
Journal of virology 2007;81(21):11925-36.
2007: Adriaan F.G. Antonis; Robbert van der Most; Yasemin Suezer; Norbert Stockhofe-Zurwieden; Franz Daus; Gerd Sutter; remco schrijver
Vaccination with recombinant modified vaccinia virus Ankara expressing bovine respiratory syncytial virus (bRSV) proteins protects calves against RSV challenge.
Vaccine 2007;25(25):4818-27.
2007: Antonio Cosma; Rashmi Nagaraj; Caroline Staib; Claudia Diemer; Franziska Wopfner; Hermann M Schätzl; Dirk H Busch; Gerd Sutter; Frank D Goebel; Volker Erfle
Evaluation of modified vaccinia virus Ankara as an alternative vaccine against smallpox in chronically HIV type 1-infected individuals undergoing HAART.
AIDS research and human retroviruses 2007;23(6):782-93.
2007: Joost H C M Kreijtz; Yasemin Suezer; Geert van Amerongen; Gerrie de Mutsert; Barbara S Schnierle; John M Wood; Thijs Kuiken; Ron A M Fouchier; Johannes Lower; Albert D M E Osterhaus; Gerd Sutter; Guus F Rimmelzwaan
Recombinant modified vaccinia virus Ankara-based vaccine induces protective immunity in mice against infection with influenza virus H5N1.
The Journal of infectious diseases 2007;195(11):1598-606.
2007: Markus Lantermann; Astrid Schwantes; Katja Sliva; Gerd Sutter; Barbara S Schnierle
Vaccinia virus double-stranded RNA-binding protein E3 does not interfere with siRNA-mediated gene silencing in mammalian cells.
Virus research 2007;126(1-2):1-8.
2007: Susanne El-Gogo; Caroline Staib; Marcus Meyr; Volker Erfle; Gerd Sutter; Heiko Adler
Recombinant murine gammaherpesvirus 68 (MHV-68) as challenge virus to test efficacy of vaccination against chronic virus infections in the mouse model.
Vaccine 2007;25(20):3934-45.
2007: Patricia Bach; Elisabeth Kamphuis; Bernhard Odermatt; Gerd Sutter; Christian J Buchholz; Ulrich Kalinke
Vesicular stomatitis virus glycoprotein displaying retrovirus-like particles induce a type I IFN receptor-dependent switch to neutralizing IgG antibodies.
Journal of immunology (Baltimore, Md. : 1950) 2007;178(9):5839-47.
2007: Christine Rollier; Glaucia Paranhos-Baccala; Ernst J Verschoor; Babs E Verstrepen; Joost A R Drexhage; Zahra Fagrouch; Jean-Luc Berland; Florence Komurian-Pradel; Blandine Duverger; Nourredine Himoudi; Caroline Staib; Marcus Meyr; Mike Whelan; Joseph A Whelan; Victoria C Adams; Victoria A Adams; Esther Larrea; José I Riezu; Juan José Lasarte; Juan José Lasarte; Birke Bartosch; Francois-L Cosset; Willy Spaan; Helmut M Diepolder; Gerd R Pape; Gerd Sutter; Genevieve Inchauspe; Jonathan Luke Heeney
Vaccine-induced early control of hepatitis C virus infection in chimpanzees fails to impact on hepatic PD-1 and chronicity.
Hepatology (Baltimore, Md.) 2007;45(3):602-13.
2007: Klaus Uberla; Brigitte Rosenwirth; Peter Ten Haaft; Jonathan Luke Heeney; Gerd Sutter; Volker Erfle
Therapeutic immunization with Modified Vaccinia Virus Ankara (MVA) vaccines in SIV-infected rhesus monkeys undergoing antiretroviral therapy.
Journal of medical primatology 2007;36(1):2-9.
2006: Caroline Staib; Yasemin Suezer; Sigrid Kisling; Ulrich Kalinke; Gerd Sutter
Short-term, but not post-exposure, protection against lethal orthopoxvirus challenge after immunization with modified vaccinia virus Ankara.
The Journal of general virology 2006;87(Pt 10):2917-21.
2006: Wolfgang Kastenmuller; Ingo Drexler; Holger Ludwig; Volker Erfle; Christian Peschel; Helga Bernhard; Gerd Sutter
Infection of human dendritic cells with recombinant vaccinia virus MVA reveals general persistence of viral early transcription but distinct maturation-dependent cytopathogenicity.
Virology 2006;350(2):276-88.
2006: Holger Ludwig; Yasemin Suezer; Zoe Waibler; Ulrich Kalinke; Barbara S Schnierle; Gerd Sutter
Double-stranded RNA-binding protein E3 controls translation of viral intermediate RNA, marking an essential step in the life cycle of modified vaccinia virus Ankara.
The Journal of general virology 2006;87(Pt 5):1145-55.
2006: Leon de Waal; Yasemin Süzer; Linda S Wyatt; Kees Sintnicolaas; Gerd Sutter; Bernard Moss; Albert D M E Osterhaus; Rik de Swart
T cell responses to respiratory syncytial virus fusion and attachment proteins in human peripheral blood mononuclear cells.
Viral immunology 2006;19(4):669-78.
2006: Melanie Kremer; Yasemin Suezer; Yolanda Martinez-Fernandez; Carsten Münk; Gerd Sutter; Barbara S Schnierle
Vaccinia virus replication is not affected by APOBEC3 family members.
Virology journal 2006;3():86.
2005: Nicolas Collin; Jean-Luc Guérin; Ingo Drexler; Sophie Blanié; Jacqueline Gelfi; Séverine Boullier; Gilles Foucras; Gerd Sutter; Frédérique Messud-Petit
The poxviral scrapin MV-LAP requires a myxoma viral infection context to efficiently downregulate MHC-I molecules.
Virology 2005;343(2):171-8.
2005: Annette Paschen; Weiqing Jing; Ingo Drexler; Moritz Klemm; Mingxia Song; Jan Muller-Berghaus; Xuan Duc Nguyen; Wolfram Osen; Stefan Stevanovic; Gerd Sutter; Dirk Schadendorf
Melanoma patients respond to a new HLA-A*01-presented antigenic ligand derived from a multi-epitope region of melanoma antigen TRP-2.
International journal of cancer. Journal international du cancer 2005;116(6):944-8.
2005: Caroline Staib; Sigrid Kisling; Volker Erfle; Gerd Sutter
Inactivation of the viral interleukin 1beta receptor improves CD8+ T-cell memory responses elicited upon immunization with modified vaccinia virus Ankara.
The Journal of general virology 2005;86(Pt 7):1997-2006.
2005: Ralf G Meyer; Cedrik Michael Britten; Ulrike Siepmann; Barbara Petzold; Tolga A Sagban; Hans-Anton Lehr; Bernd Weigle; Marc Schmitz; Luis Mateo; Burkhard Schmidt; Helga Bernhard; Thilo Jakob; Rüdiger Hein; Gerold Schuler; Beatrice Schuler-Thurner; Stephan N Wagner; Ingo Drexler; Gerd Sutter; Nathaly Arndtz; Paul Chaplin; Jost Metz; Alexander Enk; Christoph Huber; Thomas Wölfel
A phase I vaccination study with tyrosinase in patients with stage II melanoma using recombinant modified vaccinia virus Ankara (MVA-hTyr).
Cancer immunology, immunotherapy : CII 2005;54(5):453-67.
2005: Holger Ludwig; Jörg Mages; Caroline Staib; Michael H Lehmann; Roland Lang; Gerd Sutter
Role of viral factor E3L in modified vaccinia virus ankara infection of human HeLa Cells: regulation of the virus life cycle and identification of differentially expressed host genes.
Journal of virology 2005;79(4):2584-96.
2004: Ingo Drexler; Caroline Staib; Gerd Sutter
Modified vaccinia virus Ankara as antigen delivery system: how can we best use its potential?
Current opinion in biotechnology 2004;15(6):506-12.
2004: Wieslawa Olszewska; Yasemin Suezer; Gerd Sutter; Peter J M Openshaw
Protective and disease-enhancing immune responses induced by recombinant modified vaccinia Ankara (MVA) expressing respiratory syncytial virus proteins.
Vaccine 2004;23(2):215-21.
2004: Gerrit Koopman; Daniella Mortier; Sam Hofman; Henk Niphuis; Zahra Fagrouch; Stephen Norley; Gerd Sutter; Peter Liljeström; Jonathan Luke Heeney
Vaccine protection from CD4+ T-cell loss caused by simian immunodeficiency virus (SIV) mac251 is afforded by sequential immunization with three unrelated vaccine vectors encoding multiple SIV antigens.
The Journal of general virology 2004;85(Pt 10):2915-24.
2004: Barbro Mäkitalo; Peter Lundholm; Jorma Hinkula; Charlotta Nilsson; Katarina Karlén; Andreas Mörner; Gerd Sutter; Volker Erfle; Jonathan Luke Heeney; Britta Wahren; Gunnel Biberfeld; Rigmor Thorstensson
Enhanced cellular immunity and systemic control of SHIV infection by combined parenteral and mucosal administration of a DNA prime MVA boost vaccine regimen.
The Journal of general virology 2004;85(Pt 8):2407-19.
2004: Antonio Cosma; Silja Bühler; Rashmi Nagaraj; Caroline Staib; Anna-Lena Hammarin; Britta Wahren; Frank D Goebel; Volker Erfle; Gerd Sutter
Neutralization assay using a modified vaccinia virus Ankara vector expressing the green fluorescent protein is a high-throughput method to monitor the humoral immune response against vaccinia virus.
Clinical and diagnostic laboratory immunology 2004;11(2):406-10.
2004: Carina Lotz; Edite Antunes Ferreira; Ingo Drexler; Sarah Abdel Mutallib; Christoph Huber; Gerd Sutter; Matthias Theobald
Partial tyrosinase-specific self tolerance by HLA-A*0201-restricted cytotoxic T lymphocytes in mice and man.
International journal of cancer. Journal international du cancer 2004;108(4):571-9.
2004: Caroline Staib; Ingo Drexler; Gerd Sutter
Construction and isolation of recombinant MVA.
Methods in molecular biology (Clifton, N.J.) 2004;269():77-100.
2004: Felix Herrmann; Hans-Anton Lehr; Ingo Drexler; Gerd Sutter; Jan G Hengstler; Ursula Wollscheid; Barbara Seliger
HER-2/neu-mediated regulation of components of the MHC class I antigen-processing pathway.
Cancer research 2004;64(1):215-20.
2004: Kristina Fleischer; Burkhard Schmidt; Wolfgang Kastenmüller; Dirk H Busch; Ingo Drexler; Gerd Sutter; Michael Heike; Christian Peschel; Helga Bernhard
Melanoma-reactive class I-restricted cytotoxic T cell clones are stimulated by dendritic cells loaded with synthetic peptides, but fail to respond to dendritic cells pulsed with melanoma-derived heat shock proteins in vitro.
Journal of immunology (Baltimore, Md. : 1950) 2004;172(1):162-9.
2003: Antonio Cosma; Rashmi Nagaraj; Silja Bühler; Jorma Hinkula; Dirk H Busch; Gerd Sutter; Frank D Goebel; Volker Erfle
Therapeutic vaccination with MVA-HIV-1 nef elicits Nef-specific T-helper cell responses in chronically HIV-1 infected individuals.
Vaccine 2003;22(1):21-9.
2003: Massimo Di Nicola; Carmelo Carlo-Stella; Andrea Anichini; Roberta Mortarini; Anna Guidetti; Gabrina Tragni; Francesco Gallino; Michele Del Vecchio; Fernando Ravagnani; Daniele Morelli; Paul Chaplin; Nathaly Arndtz; Gerd Sutter; Ingo Drexler; Giorgio Parmiani; Natale Cascinelli; ALESSANDRO MASSIMO GIANNI
Clinical protocol. Immunization of patients with malignant melanoma with autologous CD34(+) cell-derived dendritic cells transduced ex vivo with a recombinant replication-deficient vaccinia vector encoding the human tyrosinase gene: a phase I trial.
Human gene therapy 2003;14(14):1347-60.
2003: Gerd Sutter; Caroline Staib
Vaccinia vectors as candidate vaccines: the development of modified vaccinia virus Ankara for antigen delivery.
Current drug targets. Infectious disorders 2003;3(3):263-71.
2003: Simone Hornemann; Olof Harlin; Caroline Staib; Sigrid Kisling; Volker Erfle; Bernd Kaspers; Georg Häcker; Gerd Sutter
Replication of modified vaccinia virus Ankara in primary chicken embryo fibroblasts requires expression of the interferon resistance gene E3L.
Journal of virology 2003;77(15):8394-407.
2003: Jürgen Bukur; Vera Rebmann; Hans Grosse-Wilde; Hans Luboldt; Herbert Ruebben; Ingo Drexler; Gerd Sutter; Christoph Huber; Barbara Seliger
Functional role of human leukocyte antigen-G up-regulation in renal cell carcinoma.
Cancer research 2003;63(14):4107-11.
2003: Caroline Staib; Marianne Löwel; Volker Erfle; Gerd Sutter
Improved host range selection for recombinant modified vaccinia virus Ankara.
BioTechniques 2003;34(4):694-6, 698, 700.
2003: Peter Ohlschläger; Wolfram Osen; Kerstin Dell; Stefan Faath; Robert L Garcea; Ingrid Jochmus; Martin Müller; Michael Pawlita; Klaus Schäfer; Peter Sehr; Caroline Staib; Gerd Sutter; Lutz Gissmann
Human papillomavirus type 16 L1 capsomeres induce L1-specific cytotoxic T lymphocytes and tumor regression in C57BL/6 mice.
Journal of virology 2003;77(8):4635-45.
2003: Ingo Drexler; Caroline Staib; Wolfgang Kastenmuller; Stefan Stevanović; Burkhard Schmidt; François A Lemonnier; Hans-Georg Rammensee; Dirk H Busch; Helga Bernhard; Volker Erfle; Gerd Sutter
Identification of vaccinia virus epitope-specific HLA-A*0201-restricted T cells and comparative analysis of smallpox vaccines.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(1):217-22.
2003: Caroline Staib; Gerd Sutter
Live viral vectors: vaccinia virus.
Methods in molecular medicine 2003;87():51-68.
2003: Vincenzo Bronte; paolo serafini; Carmela De Santo; Ilaria Marigo; Valeria Tosello; Alessandra Mazzoni; David M Segal; Caroline Staib; Marianne Lowel; Gerd Sutter; Mario P Colombo; Paola Zanovello
IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice.
Journal of immunology (Baltimore, Md. : 1950) 2003;170(1):270-8.
2002: Koert J Stittelaar; Rob A Gruters; Martin Schutten; Carel A van Baalen; Geert van Amerongen; Martin Cranage; Peter Liljeström; Gerd Sutter; Albert D M E Osterhaus
Comparison of the efficacy of early versus late viral proteins in vaccination against SIV.
Vaccine 2002;20(23-24):2921-7.
2002: Li-Xin Zhu; Jing Liu; Ying-Chun Li; Yu-Ying Kong; Caroline Staib; Gerd Sutter; Yuan Wang; Guang-Di Li
Full-length core sequence dependent complex-type glycosylation of hepatitis C virus E2 glycoprotein.
World journal of gastroenterology : WJG 2002;8(3):499-504.
2002: Charlotta Nilsson; Gerd Sutter; Lilian Walther-Jallow; Peter Ten Haaft; Lennart Akerblom; Jonathan Luke Heeney; Volker Erfle; Per Böttiger; Gunnel Biberfeld; Rigmor Thorstensson
Immunization with recombinant modified vaccinia virus Ankara can modify mucosal simian immunodeficiency virus infection and delay disease progression in macaques.
The Journal of general virology 2002;83(Pt 4):807-18.
2002: Jean-Luc Guerin; Jacqueline Gelfi; Severine Boullier; Maxence Delverdier; Frederique-Anne Bellanger; Stéphane Bertagnoli; Ingo Drexler; Gerd Sutter; Frédérique Messud-Petit
Myxoma virus leukemia-associated protein is responsible for major histocompatibility complex class I and Fas-CD95 down-regulation and defines scrapins, a new group of surface cellular receptor abductor proteins.
Journal of virology 2002;76(6):2912-23.
2001: Barbara Seliger; Ulrike Ritz; Rupert Abele; Michaela Bock; Robert Tampé; Gerd Sutter; Ingo Drexler; Christoph Huber; Soldano Ferrone
Immune escape of melanoma: first evidence of structural alterations in two distinct components of the MHC class I antigen processing pathway.
Cancer research 2001;61(24):8647-50.
2001: Sally A Sharpe; Natasha Polyanskaya; Mike Dennis; Gerd Sutter; Tomás Hanke; V Erfle; Vanessa M Hirsch; Martin Cranage
Induction of simian immunodeficiency virus (SIV)-specific CTL in rhesus macaques by vaccination with modified vaccinia virus Ankara expressing SIV transgenes: influence of pre-existing anti-vector immunity.
The Journal of general virology 2001;82(Pt 9):2215-23.
2001: Charlotta Nilsson; Barbro Mäkitalo; P Berglund; Françoise Bex; Peter Liljeström; Gerd Sutter; Volker Erfle; Peter Ten Haaft; Jonathan Luke Heeney; Gunnel Biberfeld; Rigmor Thorstensson
Enhanced simian immunodeficiency virus-specific immune responses in macaques induced by priming with recombinant Semliki Forest virus and boosting with modified vaccinia virus Ankara.
Vaccine 2001;19(25-26):3526-36.
2001: Gerald Weidinger; M Ohlmann; Bernd Schlereth; Gerd Sutter; Stefan Niewiesk
Vaccination with recombinant modified vaccinia virus Ankara protects against measles virus infection in the mouse and cotton rat model.
Vaccine 2001;19(20-22):2764-8.
2001: Gerd Sutter; J Haas
Novel vaccine delivery systems: solutions to HIV vaccine dilemmas?
AIDS (London, England) 2001;15 Suppl 5():S139-45.
2000: Catherine Wölfel; Ingo Drexler; Aline Van Pel; T Thres; N Leister; Wolfgang Herr; Gerd Sutter; Christoph Huber; Thomas Wölfel
Transporter (TAP)- and proteasome-independent presentation of a melanoma-associated tyrosinase epitope.
International journal of cancer. Journal international du cancer 2000;88(3):432-8.
2000: Jonathan Luke Heeney; Gerrit Koopman; Brigitte Rosenwirth; Willy M J M Bogers; J van Dijk; Ivonne G Nieuwenhuis; Henk Niphuis; Peter Ten Haaft; T Hanke; Gary H Rhodes; P Berglund; Arsène Burny; Françoise Bex; Gerd Sutter; Peter Liljeström
A vaccine strategy utilizing a combination of three different chimeric vectors which share specific vaccine antigens.
Journal of medical primatology 2000;29(3-4):268-73.
2000: Caroline Staib; Ingo Drexler; M Ohlmann; S Wintersperger; Volker Erfle; Gerd Sutter
Transient host range selection for genetic engineering of modified vaccinia virus Ankara.
BioTechniques 2000;28(6):1137-42, 1144-6, 1148.
1999: B Kohleisen; E Shumay; Gerd Sutter; R Foerster; Ruth Brack-Werner; M Nuesse; Volker Erfle
Stable expression of HIV-1 Nef induces changes in growth properties and activation state of human astrocytes.
AIDS (London, England) 1999;13(17):2331-41.
1999: Ingo Drexler; E Antunes; M Schmitz; Thomas Wölfel; C Huber; Volker Erfle; P Rieber; Matthias Theobald; Gerd Sutter
Modified vaccinia virus Ankara for delivery of human tyrosinase as melanoma-associated antigen: induction of tyrosinase- and melanoma-specific human leukocyte antigen A*0201-restricted cytotoxic T cells in vitro and in vivo.
Cancer research 1999;59(19):4955-63.
1999: Brigitte Rosenwirth; Willy M J M Bogers; Ivonne G Nieuwenhuis; Peter Ten Haaft; Henk Niphuis; EM Kuhn; N Bischofberger; Volker Erfle; Gerd Sutter; P Berglund; Peter Liljestrom; Klaus Uberla; Jonathan Luke Heeney
An anti-HIV strategy combining chemotherapy and therapeutic vaccination.
Journal of medical primatology 1999;28(4-5):195-205.
1999: Albert D M E Osterhaus; Carel A van Baalen; Rob A Gruters; Martin Schutten; C H Siebelink; EG Hulskotte; E J Tijhaar; R E Randall; Geert van Amerongen; A Fleuchaus; V Erfle; Gerd Sutter
Vaccination with Rev and Tat against AIDS.
Vaccine 1999;17(20-21):2713-4.
1999: K Geissler; K Schneider; A Fleuchaus; C R Parrish; Gerd Sutter; Uwe Truyen
Feline calicivirus capsid protein expression and capsid assembly in cultured feline cells.
Journal of virology 1999;73(1):834-8.
1998: Massimo Di Nicola; Salvatore Siena; Marco Bregni; Paolo Longoni; Michele Magni; Marco Milanesi; Paola Matteucci; Roberta Mortarini; Andrea Anichini; Giorgio Parmiani; Ingo Drexler; Volker Erfle; Gerd Sutter; ALESSANDRO MASSIMO GIANNI
Gene transfer into human dendritic antigen-presenting cells by vaccinia virus and adenovirus vectors.
Cancer gene therapy 1998;5(6):350-6.
1998: Frédérique Messud-Petit; Jacqueline Gelfi; Maxence Delverdier; MF Amardeilh; R Py; Gerd Sutter; Stéphane Bertagnoli
Serp2, an inhibitor of the interleukin-1beta-converting enzyme, is critical in the pathobiology of myxoma virus.
Journal of virology 1998;72(10):7830-9.
1998: Ingo Drexler; K Heller; Britta Wahren; Volker Erfle; Gerd Sutter
Highly attenuated modified vaccinia virus Ankara replicates in baby hamster kidney cells, a potential host for virus propagation, but not in various human transformed and primary cells.
The Journal of general virology 1998;79 ( Pt 2)():347-52.
1997: Jorma Hinkula; C Svanholm; S Schwartz; Peter Lundholm; M Brytting; Gunnel Engström; Reinhold Benthin; H Glaser; Gerd Sutter; B Kohleisen; Volker Erfle; Kenji Okuda; Hans Wigzell; Britta Wahren
Recognition of prominent viral epitopes induced by immunization with human immunodeficiency virus type 1 regulatory genes.
Journal of virology 1997;71(7):5528-39.
1995: Gerd Sutter; M Ohlmann; Volker Erfle
Non-replicating vaccinia vector efficiently expresses bacteriophage T7 RNA polymerase.
FEBS letters 1995;371(1):9-12.
1991: H Meyer; Gerd Sutter; A Mayr
Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence.
The Journal of general virology 1991;72 ( Pt 5)():1031-8.